# NALOXONE HYDROCHLORIDE

NDC: 45802-578
Generic name: naloxone hydrochloride
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SPRAY
Routes: NASAL
Marketing started: 20230730

FDA application: ANDA211951

## Active ingredients

- NALOXONE HYDROCHLORIDE: 4 mg/.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-578"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-578
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5d40220-f194-4835-b70c-f304ecb222d5
